Socio-demographic and comorbid risk factors for poor prognosis in patients hospitalized with community-acquired bacterial pneumonia in southeastern US
Thirty percent of all adult community-acquired pneumonia (CAP) are hospitalized annually in the US, estimated at over 1.5 million patients and 100,000 deaths annually.1 Hospitalization for CAP is influenced by chronic comorbidity and socio-demographic risk factors.1-3 Chronic comorbidities known for the highest incidence of CAP hospitalization include chronic obstructive pulmonary disease (COPD), congestive heart failure, stroke, type 2 diabetes, and obesity.1 The estimated annual incidence of hospitalization for CAP due to these comorbidities ranges from 674 hospitalizations per 100,000 adults for obesity to 5832 hospital...
Source: Heart and Lung - February 20, 2024 Category: Intensive Care Authors: Adeniyi J. Idigo, J. Michael Wells, Matthew L. Brown, Howard W. Wiener, Russell L. Griffin, Gary Cutter, Sadeep Shrestha, Rachael A. Lee Source Type: research
Global, regional, and national time trends in incidence for tuberculosis, 1990 −2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study
Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis [1], with approximately 10 million new cases and 1.4 million associated mortalities globally in 2019 [2,3]. The World Health Organization and the United Nations adopted the End TB Strategy and the Sustainable Development Goals (SDGs) in 2014 and 2015 respectively, with the objective of reducing TB incidence by 80 % and TB mortality by 90 % between 2015 and 2030, and ultimately eradicating the global TB epidemic by 2030 [4,5]. (Source: Heart and Lung)
Source: Heart and Lung - February 19, 2024 Category: Intensive Care Authors: Qi-Wen Lan, Hao-Kai Chen, Ze-Min Huang, Ting-Yu Bao, Chuang-Jia Liang, Rui-Ting Yi, Yuan-Yi Huang, Ying-Xin He, Xu-Qi Huang, Bing Gu, Xu-Guang Guo, Qing-Wei Zhang Source Type: research
Development and validation of a diagnostic nomogram in pulmonary hypertension due to left heart disease
The risk factors affecting the presence of pulmonary hypertension (pH) due to left heart disease (pH-LHD) remains unclear. The prevalence of pH-LHD is variable, depending on different diagnostic methods, pH definitions and study populations. It is estimated that about 36 –83 % of heart failure with preserved ejection fraction (HFpEF) patients and 40–75 % of heart failure with reduced ejection fraction (HFrEF) patients may develop pH.1–5 Patients with heart failure (HF) and pH often have worse left ventricular function and poorer prognosis. (Source: Heart and Lung)
Source: Heart and Lung - February 16, 2024 Category: Intensive Care Authors: Shi Shi, Xu Zhu, Iokfai Cheang, Shengen Liao, Ting Yin, Xinyi Lu, Wenming Yao, Haifeng Zhang, Xinli Li, Yanli Zhou Source Type: research
Nursing care of the patient hospitalized with heart failure: A scientific statement from the American Association of Heart Failure Nurses
Heart failure (HF) is a prevalent cardiovascular condition associated with substantial mortality and financial burden. Approximately 6.5 million adults in the United States (US) (1 in 4 people) will develop HF in their lifetime, with projections trending to upwards of 8.5 million people by 20301. HF mortality rates have increased since 2012 for both men and women, with a greater annual increase in 35- to 64-year-old adults, compared to older, 65- to 84-year-olds.1 It is estimated that, by 2030, HF costs in the US will be at least $70 billion per year, with 75 –80 % of the costs attributable to HF hospitalizations, alone....
Source: Heart and Lung - February 13, 2024 Category: Intensive Care Authors: Meg Fraser, Stephanie G. Barnes, Carol Barsness, Craig Beavers, Cynthia J. Bither, Samantha Boettger, Christine Hallman, Anne Keleman, Lauren Leckliter, Colleen K. McIlvennan, Cemal Ozemek, Amit Patel, Natalie W. Pierson, Courtney Shakowski, S. Craig Thom Source Type: research
Effectiveness of virtual reality-based therapy in pulmonary rehabilitation of chronic obstructive pulmonary disease. A systematic review with meta-analysis
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition marked by difficulty breathing due to airflow obstruction, with significant sequelae including respiratory failure, cardiovascular risk, and lung cancer.1 –3 Currently, COPD is the most prevalent chronic respiratory disease, with a global prevalence of 10.6 %4 (impacting 2.7 million patients annually5). Sedentary lifestyle, smoke, air pollution, among others, are key risk factors for the projected increase in global prevalence by 23 % in 2050, espec ially in women,4,6 and COPD is expected to become the third most common diseases by 2030. ...
Source: Heart and Lung - February 7, 2024 Category: Intensive Care Authors: Esteban Obrero-Gait án, Celim Yem Chau-Cubero, Rafael Lomas-Vega, María Catalina Osuna-Pérez, Héctor García-López, Irene Cortés-Pérez Source Type: research
Nursing care of the patient hospitalized with heart failure: Executive summary: A Scientific statement from the American association of heart failure nurses
Over 6.5 million adults in the United States (US) have a diagnosis of heart failure (HF), and this prevalence is projected to increase to over 8 million people by 20301. HF is a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion2. HF is the primary diagnosis for US hospitalizations with approximately 1.3 million each year and remains the most common cause of hospitalization for patients 65 years or older. (Source: Heart and Lung)
Source: Heart and Lung - February 7, 2024 Category: Intensive Care Authors: Meg Fraser, Stephanie G. Barnes, Carol Barsness, Craig Beavers, Cynthia J. Bither, Samantha Boettger, Christine Hallman, Anne Keleman, Lauren Leckliter, Colleen K. McIlvennan, Cemal Ozemek, Amit Patel, Natalie W. Pierson, Courtney Shakowski, S. Craig Thom Source Type: research
Addressing the functional needs of left ventricular assist device candidates: Development and feasibility of an occupational therapy pre-operative evaluation
Over 27,000 left ventricular assist devices (LVADs) were implanted in the United States in the past decade.1 Daily living with an LVAD involves complex demands such as managing power sources, monitoring for complications, integrating the device into daily activities, and preparing for emergencies.2 Impaired cognition and frailty are sequelae of end-stage heart failure (HF) that further challenge daily living.3 –6 Destination therapy is now the most common LVAD indication, and since 2018, LVAD patients are older and have higher comorbidity burdens than in previous years. (Source: Heart and Lung)
Source: Heart and Lung - January 31, 2024 Category: Intensive Care Authors: Jessica D. Asiello, Christina M. Kelley, Kellie Cannone, Lauren McInnis, Abigail Begin, Marissa Dittrich, Erin Donovan, Kimberly Beatty, Nicole Lam, Alyssa Taubert, John Wong Source Type: research
Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study
Pulmonary arterial hypertension (PAH) is characterized by structural or functional alterations of the pulmonary vasculature resulting from various heterogenous diseases (etiology) and distinct pathogenesis, characterized essentially by increased pulmonary vascular resistance (PVR) and reduced pulmonary arterial compliance (PAC). Ultimately, these alterations can lead to irreversible right heart failure or, in severe cases, even mortality.1 The adult incidence of PAH ranges from 2.4 to 5.8 cases per million person-years, with a 5-year survival rate of only 65.4 % due to the absence of early clinical symptoms and the lack ...
Source: Heart and Lung - January 30, 2024 Category: Intensive Care Authors: Chenwei Zhang, Yujia Xi, Yukai Zhang, Peiyun He, Xuesen Su, Yishan Li, Mengyuan Zhang, Haizhao Liu, Xiao Yu, Yiwei Shi Source Type: research
Network analysis of perception of exercise benefits/barriers and kinesiophobia among patients with cardiovascular diseases
Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality worldwide, accounting for an estimated 17.9 million deaths annually.1 In China, CVDs were also the top cause of death in urban and rural areas, comprising 45.9 % and 48.0 % of all deaths in 2020, respectively.2 Cardiac rehabilitation is recommended as useful and effective (Class 1) measures to deliver secondary prevention in the treatment of CVDs by the American Heart Association (AHA).3 Physical activity and exercise are recognized as core components and strategie s of cardiac rehabilitation for improving patients’ health-related outcomes....
Source: Heart and Lung - January 27, 2024 Category: Intensive Care Authors: Yi Zhou, Xiaopei Gao, Jiangyuan Xu, Xiaojuan Ding, Jing Yuan, Shaoying Du, Xiaoyang Shi, Yan Wang Source Type: research
Oxygen debt as a predictor of high-flow nasal cannula therapy failure in SARS-CoV-2 patients with acute respiratory failure: A retrospective cohort study
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is characterized by its rapid progression to acute hypoxemic respiratory failure (AHRF),1 with a prevalence between 20% and 40%.2 It requires increased oxygen therapy and, in the case of progression, orotracheal intubation (OTI) to avoid self-inflicted lung injury (SILI).3 (Source: Heart and Lung)
Source: Heart and Lung - January 25, 2024 Category: Intensive Care Authors: Perez-Garzon Michel, Poveda-Henao Claudia, Rozo-Salinas Andrea, Diaz-Ardila Maria, Robayo-Amortegui Henry Source Type: research
Association between prehospital time and in-hospital outcomes in out-of-hospital cardiac arrests according to resuscitation outcomes consortium epidemiologic registry
Out-of-hospital cardiac arrest (OHCA) stands as a sudden and urgent medical emergency, posing a formidable threat to the lives of the stricken individuals.1 Despite many advances in relieving and treating victims in cardiac arrest, a substantial proportion, up to one-third, of patients with acute manifestations of heart disease are unable to reach the hospital post-cardiac arrest. Epidemiological surveys conducted in North America and Europe underscore a disheartening reality: annually, over 500,000 lives succumb to OHCA, with a mere 8 % of OHCAs culminating in survival. (Source: Heart and Lung)
Source: Heart and Lung - January 19, 2024 Category: Intensive Care Authors: Yuting Pu, Xiangping Chai, Guifang Yang Source Type: research
Telehealth care and remote monitoring strategies in heart failure patients: A systematic review and meta-analysis
Heart failure (HF) is a cardiac clinical syndrome that can arise as a consequence of various conditions, even those not directly associated with the myocardium.1 –4 HF poses a significant public health issue as it is a chronic condition that generally worsens over time, usually cannot be cured, and available data highlight that millions of people (ranging from 23 to 64.3 million) are affected worldwide.5–8 The prevalence is generally 1% to 2% of the gene ral adult population in developed countries, rising to up to 10% in people aged over 70. (Source: Heart and Lung)
Source: Heart and Lung - January 18, 2024 Category: Intensive Care Authors: Vittorio Masotta, Angelo Dante, Valeria Caponnetto, Alessia Marcotullio, Fabio Ferraiuolo, Luca Bertocchi, Francesco Camero, Loreto Lancia, Cristina Petrucci Source Type: research
Lower cardiac rehabilitation enrolment occurs in acute coronary syndrome patients who report low levels of physical activity at four weeks post-event: A prospective observational study using physical activity tracker data
Physical activity (PA) is a crucial component in the management and secondary prevention of cardiovascular disease (CVD). Several studies have demonstrated that higher levels of PA protect against mortality and cardiovascular events for individuals with established CVD.1,2 Moreover, individuals with CVD who maintain or improve their level of PA over time tend to experience the greatest survival and cardiovascular health benefits, even if they have historically been inactive.3 For individuals who experience acute coronary syndrome (ACS), PA plays a pivotal role in supporting recovery and prognosis. (Source: Heart and Lung)
Source: Heart and Lung - January 11, 2024 Category: Intensive Care Authors: Matthew Hollings, Emma Zhao, Joseph Weddell, Sharon Naismith, Geoffrey Tofler, Adrian Bauman, Robyn Gallagher Source Type: research
Corrigendum to “Effects of ventilatory bundles on patient outcomes among ICU patients: A systematic review and meta-analysis’’ [Heart & Lung, volume 63 (2024), 98-107]
The authors regret that the printed version of the above article did not include the full list of affiliations for the 5th author and must be corrected as above. (Source: Heart and Lung)
Source: Heart and Lung - January 9, 2024 Category: Intensive Care Authors: Dejina Thapa, Sek Ying Chair, Mei Sin Chong, Rishi Ram Poudel, Tenaw Gualu Melesse, Kai Chow Choi, Hon Lon Tam Source Type: research
Network Analysis on Family Resilience, Fear of Progression, and Quality of Life in Chinese Patients with Pulmonary Hypertension
Pulmonary hypertension (PH) is a pathological condition characterized by a resting mean pulmonary artery pressure of ≥25 mmHg 1. It is a primary chronic pulmonary vascular disease and a common comorbidity of conditions related to abnormal cardiopulmonary and renal function 2-4. PH is a rapidly progressive condition with a high rate of death and disability 5. A recent study demonstrated a 2% increase in the age-a djusted yearly mortality rate attributed to PH between 1999 and 2019 6. Globally, PH has become a considerable public health issue 6. (Source: Heart and Lung)
Source: Heart and Lung - January 3, 2024 Category: Intensive Care Authors: Mengqi LIU, Xiaoli WANG, Zeping YAN, Zhiwei WANG, Huimin WEI, Jiurui WANG, Xiaorong LUAN Source Type: research
